Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
PROT# 6517-CL-0020: A Phase 3b Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Vernakalant Hydrochloride Injection in Patients with Recent Onset Symptomatic Atrial Fibrillation
Passman, Rod S
(PD/PI)
Medicine, Cardiology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
7/16/10
→
7/16/13
Funding
Astellas Pharma Global Development, Inc.
(Prot # 6517-CL-0020)
View all
View less